Cite
HARVARD Citation
Baker, C. et al. (2019). Dose‐dependent glycometabolic effects of sotagliflozin on type 1 diabetes over 12 weeks: The inTandem4 trial. Diabetes, obesity & metabolism. 21 (11), pp. 2440-2449. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Baker, C. et al. (2019). Dose‐dependent glycometabolic effects of sotagliflozin on type 1 diabetes over 12 weeks: The inTandem4 trial. Diabetes, obesity & metabolism. 21 (11), pp. 2440-2449. [Online].